Ocular TherapeutixTM Announces Plans to Proceed with an NDA Submission for OTX-DP for Treatment of Post-Surgical Ocular Pain Indication; Reports First Quarter 2015 Financial Results

Go back to Ocular TherapeutixTM Announces Plans to Proceed with an NDA Submission for OTX-DP for Treatment of Post-Surgical Ocular Pain Indication; Reports First Quarter 2015 Financial Results
(NASDAQ: OCUL) Delayed: 9.97 +0.54 (5.73%)
Previous Close $9.43    52 Week High $14.50 
Open $9.51    52 Week Low $4.04 
Day High $10.14    P/E N/A 
Day Low $9.41    EPS $0.00 
Volume 5,162,262